SCHEMBL8530461

SCHEMBL8530461

NS(=O)(=O)c1ccc2c(c1)C(=Cc1ccc3ccccc3c1)C(=O)N2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.61
SYK P43405 5/20 0.58
NTRK1 P04629 5/20 0.58
NTRK3 Q16288 3/20 0.55
NTRK2 Q16620 3/20 0.55
FCER2 P06734 2/20 0.55
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
SRC P12931 2/20 0.52
KDR P35968 2/20 0.52
PDGFRB P09619 1/20 0.52
FGFR1 P11362 1/20 0.52
CDK2 P24941 1/20 0.51
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8527809 0.88 KDM4E (0.54) PDPK1KDM4EALDH1A1GAAMAPT
SCHEMBL5182059 0.83 PDPK1 (0.60) PDPK1SYKNTRK1NTRK3NTRK2
SCHEMBL5182063 0.83 PDPK1 (0.60) PDPK1SYKNTRK1NTRK3NTRK2
SCHEMBL5474941 0.81 MAPT (0.68) KDM4EALDH1A1GAAMAPTKDR
SCHEMBL5474945 0.81 MAPT (0.68) KDM4EALDH1A1GAAMAPTKDR
SCHEMBL5472246 0.80 LRRK2 (0.73) KDM4EALDH1A1GAAMAPTPDGFRB
SCHEMBL5472244 0.80 LRRK2 (0.73) KDM4EALDH1A1GAAMAPTPDGFRB
SCHEMBL8526924 0.80 PDPK1 (0.60) PDPK1KDM4EALDH1A1GAAMAPT
SCHEMBL6394720 0.79 PDPK1 (0.65) PDPK1SYKNTRK1NTRK3NTRK2
SCHEMBL6394717 0.79 PDPK1 (0.65) PDPK1SYKNTRK1NTRK3NTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed